AZD4547 & Anastrozole or Letrozole (NSAIs) in ER+ Breast Cancer Patients Who Have Progressed on NSAIs (RADICAL)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: AZD4547 / anastrozole or letrozole
Sponsor: Imperial College London
Collaborators: Cancer Research UK|AstraZeneca